Los Altos

Stevie® Award Winners Announced in The 21st American Business Awards®

Retrieved on: 
Thursday, April 27, 2023
Abas, Premier, Inc., Clemson, Georgia Dome, Stevie Awards, Face, RI, Fidelity Investments, Organization, Align Technology, AT, COVID-19, Creativity, Chicago, European-American Business Organization, Gold, Delta Dental, Tata Consultancy Services, Malvern, Lehi, HCLTech, IBM, Marriott Marquis, Los Altos, Texas Department of Transportation, Sale, Swedish Business Awards, Washington Marriott Marquis, Auction, Nightclub, Film industry, Vanguard, Silver, Conford

FAIRFAX, Va., April 27, 2023 /PRNewswire-PRWeb/ -- The Stevie® Awards, organizers of the world's premier business awards programs, today announced the Gold, Silver, and Bronze Stevie winners in The 21st American Business Awards®.

Key Points: 
  • FAIRFAX, Va., April 27, 2023 /PRNewswire-PRWeb/ -- The Stevie® Awards, organizers of the world's premier business awards programs, today announced the Gold, Silver, and Bronze Stevie winners in The 21st American Business Awards® .
  • Winners of six best-of-show prizes will be awarded Grand Stevie Award trophies, to be announced the week of May 8.
  • "We are thrilled to be able to recognize such a wide array of American organizations in The 2023 American Business Awards.
  • "This year's Stevie-winning nominations in The American Business Awards are testament to the commitment, passion, adaptability, and creativity of American professionals.

Intero Announces Role Changes for Key Executives, Exemplifying the Strengths of its Seasoned Leaders

Retrieved on: 
Saturday, February 18, 2023
Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Opes, Insurance, Mentorship, General counsel, Chase, Silver, Hollister, MLS, Berkshire Hathaway, Moles, Barsanti, HomeServices of America, Culture, Sheri, Education, Growth, Wolfgram, Creativity, Crane, Best, Los Altos, Management, Mergers and acquisitions

“At Intero, we are constantly evolving to optimize the talents and skills of our seasoned leaders, and to stay ahead of the competition,” said Brian Crane, CEO.

Key Points: 
  • “At Intero, we are constantly evolving to optimize the talents and skills of our seasoned leaders, and to stay ahead of the competition,” said Brian Crane, CEO.
  • Chase joined Intero in November of 2018 after a successful stint as regional sales manager at Opes Advisors.
  • “When agents come to Intero, they come to learn from the best in the business,” said Chase.
  • As an Intero co-founder in 2002, Meyer opened Intero’s first San Jose office, located in the Willow Glen area.

Deeplite Supports tinyML Foundation as Platinum Strategic Partner

Retrieved on: 
Tuesday, February 15, 2022
Cloud, Ecosystem, CRN, AI, Perception, ARM, Harvard University, ML, Solution, EdX, Stanford University, Efficiency, Budget, Silicon, Machine learning, NXP Semiconductors, Technology, Los Altos, Samsung Electronics, Gartner, Deep learning, Software, Qualcomm, Growth, Multimedia, Intelligence, Life, Organization, Medical device, Renewable energy, Video game, Video game console, Forbes

MONTREAL, Feb. 15, 2022 /PRNewswire/ -- Deeplite , a provider of AI optimization software designed to make AI model inference faster, more compact and energy-efficient, today announced it has sponsored the tinyML Foundation as a platinum partner and a member of its strategic partner advisory board.

Key Points: 
  • MONTREAL, Feb. 15, 2022 /PRNewswire/ -- Deeplite , a provider of AI optimization software designed to make AI model inference faster, more compact and energy-efficient, today announced it has sponsored the tinyML Foundation as a platinum partner and a member of its strategic partner advisory board.
  • Deeplite is a charter member of regional tinyML Meetups in Canada through its local chapter in Montreal, as well as Toronto.
  • "Being a Platinum Strategic Partner of the tinyML Foundation helps us advance the technology vision of tinyML and bring it to real-world applications.
  • "We look forward to collaborating further with Deeplite as a Platinum Strategic Partner, as we work together to enable edge AI deployments for more devices and applications," said Ira Feldman, managing director of the tinyML Foundation.

LEBRON JAMES SPORTS ALL FOUR CHAMPIONSHIP RINGS AS HE UNVEILS NEW BOTTLE FOR LOBOS 1707 EXTRA AÑEJO TEQUILA

Retrieved on: 
Tuesday, February 1, 2022
CEO, Culture, Cleveland Cavaliers, Miami Heat, MVP, 2010–11 Miami Heat season, 1972 NBA Finals, LeBron James, 2016 Championships of the Small States of Europe, Social media, Los Altos, NBA Finals, Dia Simms, NBA, Glass, Multimedia, History, Lobos 1707, Liquor, Mezcal

NEW YORK, Feb. 1, 2022 /PRNewswire/ --In celebration of an iconic moment, four-time NBA champion LeBron James dons all of his Championship rings to debut Lobos 1707 Tequila and Mezcal's new Extra Aejo tequila bottle, which LeBron is seen holding in the photo.

Key Points: 
  • NEW YORK, Feb. 1, 2022 /PRNewswire/ --In celebration of an iconic moment, four-time NBA champion LeBron James dons all of his Championship rings to debut Lobos 1707 Tequila and Mezcal's new Extra Aejo tequila bottle, which LeBron is seen holding in the photo.
  • Extra Aejo is the MVP and crown jewel of the Lobos 1707 tequila portfolio.
  • LeBron James is an investor and shareholder of Lobos 1707 Tequila and Mezcal.
  • The Lobos 1707 Tequila and Mezcal portfolio is made up of four super premium offerings: Lobos 1707 Joven Tequila, Lobos 1707 Reposado Tequila, Lobos 1707 Extra Aejo Tequila, and Lobos 1707 Mezcal Artesanal, all premium products infused with history, culture and family legacy.

Paulina Rubio is at It Again as She Kicks Off Her Summer Concerts 2022 Series and Takes Her Tequila With Her

Retrieved on: 
Wednesday, January 26, 2022
Grammy Awards, GHT, Grand Prairie, Texas, Total Wine & More, Golden Girl, Los Altos, Smart Financial Centre, Female, GLOBE, Nightclub

If you haven't heard of GHT yet, you will.

Key Points: 
  • If you haven't heard of GHT yet, you will.
  • It just hit the shelves at Total Wines & More in Texas and CA.The tequila is quite remarkable with its slight habanero finish.
  • It is tequila at its core - 100% blue weber agave from the Los Altos (highlands) region of Jalisco.
  • Both artists have sold more than 20 million albums worldwide and are two of the most successful female artists from Mexico.

Wordly Expands Real-Time AI Interpretation for Zoom Meetings

Retrieved on: 
Monday, November 1, 2021
API, Integrated Genome Browser, Organization, GLOBE, LOS, CEO, AI, Language, Mobile phone, Medical device

LOS ALTOS, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Wordly , Inc. today announced the launch of Wordly App for Zoom, a new Zoom App delivering an enhanced embedded experience accessible within Zoom Meetings.

Key Points: 
  • LOS ALTOS, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Wordly , Inc. today announced the launch of Wordly App for Zoom, a new Zoom App delivering an enhanced embedded experience accessible within Zoom Meetings.
  • Wordly provides real-time translation powered by AI and translates from 15 languages into 21 languages - providing fast, accurate, and affordable interpretation on-demand.
  • "The new Wordly AI-based real-time translation for all attendees is an excellent example of Zoom enabling more powerful unified communications," said Ross Mayfield, Product Lead Zoom Apps and Integrations for Zoom.
  • Wordly delivers uniquely scalable, affordable, and always-available simultaneous interpretation to make meetings, webinars, and conferences more productive, inclusive, and engaging.

Mpowered Health Announces Partnership with eHealth to Help Consumers Select and Enroll in Medicare and Individual & Family Health Insurance Plans

Retrieved on: 
Thursday, October 21, 2021
Technology, Industry, Medicare Advantage, Medigap, Human, Partnership, Family, NASDAQ, General manager, Strategic partnership, EHealth, Small business, LOS, Review, Medicare Part D, Founder CEO, District, Medicare, CEO, Solution, Nandini, GLOBE, Population, Health insurance

LOS ALTOS, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Mpowered Health , a consumer health empowerment company, today announced a partnership with eHealth, Inc. ( www.ehealth.com ), a leading online health insurance marketplace.

Key Points: 
  • LOS ALTOS, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Mpowered Health , a consumer health empowerment company, today announced a partnership with eHealth, Inc. ( www.ehealth.com ), a leading online health insurance marketplace.
  • eHealth, Inc. (NASDAQ: EHTH) operates a leading health insurance marketplace at eHealth.com and eHealthMedicare.com with technology that provides consumers with health insuranceenrollment solutions.
  • Since 1997, eHealth has connected more than 8 million members with quality, affordable health insurance, Medicare options, and ancillary plans.
  • eHealth's proprietary marketplace offers Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual, family, small business and other plans from over 200 health insurance carriers across 50 states and the District of Columbia.

Positive Results from Studies of Retrotope’s RT011 in Animal Models of Retinal Degeneration to be Featured in Oral Presentations at 2nd Annual Dry AMD Therapeutic Development Summit

Retrieved on: 
Tuesday, October 19, 2021
ALS, IND, Visual impairment, Tissue, Death, PUFA, Cell damage, Investigational New Drug, Western world, FA, Reading, Oxidative stress, GLOBE, Patient, University, INAD, Animal, RT001, LA, Retinal pigment epithelium, Demonstration, GA, AMD, Infantile neuroaxonal dystrophy, Collection, Amyotrophic lateral sclerosis, Time, DHA, University of Pennsylvania, Vicious Circle, RATS, Disease, Drusen, LPO, Time-invariant system, Retina, Dihydroxy-E,Z,E-PUFA, Geographic atrophy, Inflammation, Central retinal artery occlusion, Degenerative disease, Dry, Injection, Â, Severe cognitive impairment, RPE, Lipid peroxidation, LOS, Program, Research, Stress (linguistics), PSP, Therapy, Vaccine, Pharmaceutical industry, Dietary supplement

LOS ALTOS, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases, today announced that positive results from preclinical studies of RT011, the second compound to emerge from the company’s novel technology platform, are being reported in multiple oral presentations at the 2nd Annual Dry AMD Therapeutic Development Summit. Findings to be presented demonstrate that RT011, which is being developed as an oral therapy for the treatment of dry age-related macular degeneration (AMD), provided dose-dependent protection in animal models of oxidative damage implicated in dry AMD. Importantly, study results showed that animals treated with RT011 experienced preservation of retinal cells, photoreceptors, and visual function relative to control animals. The conference, which is being conducted in a virtual format, is being held October 19-21, 2021.

Key Points: 
  • Findings to be presented demonstrate that RT011, which is being developed as an oral therapy for the treatment of dry age-related macular degeneration (AMD), provided dose-dependent protection in animal models of oxidative damage implicated in dry AMD.
  • Importantly, study results showed that animals treated with RT011 experienced preservation of retinal cells, photoreceptors, and visual function relative to control animals.
  • The company expects to file an Investigational New Drug (IND) application for RT011 in the first half of 2022 and initiate first-in-human clinical studies in dry AMD soon thereafter.
  • Study results demonstrated that animals treated with RT011 experienced decreasing levels of retinal damage with increasing tissue concentrations of RT011.

Mpowered Health launches healthcare's next-generation 'digital front door' with industry's first FHIR®-compliant member portal

Retrieved on: 
Thursday, October 7, 2021
Directory, Founder CEO, GLOBE, Ensuring Patient Access and Effective Drug Enforcement Act, Industry, Population, Bankers Healthcare Group, Provider, Nandini, CMS, Medicare, LOS, CEO, Record, Pharmacy, Solution, Compliance, Acquisition, Human, Health insurance

Mpowered Health's member portal , the industry's first FHIR-complaint portal, enables payers and providers to deliver24/7 on-demand access to health information for their members, be it medical, financial, care or other information.

Key Points: 
  • Mpowered Health's member portal , the industry's first FHIR-complaint portal, enables payers and providers to deliver24/7 on-demand access to health information for their members, be it medical, financial, care or other information.
  • The highly configurable portal is already integrated with Mpowered Health's CMS 9115F compliance solution to deliver 100% compliance with CMS Interoperability and Patient Access Rule.
  • Prior to founding Mpowered Health, Nandini co-founded ZeOmega and helped scale it into one of the largest population health management solutions companies in the industry.
  • Mpowered Health is a consumer-driven healthcare technology company committed to creating a better healthcare experience for consumers and enterprises.

Retrotope Reports Data from Phase 2/3 Clinical Trial of RT001 and Concurrent Natural History Study in Patients with Infantile Neuroaxonal Dystrophy (INAD)

Retrieved on: 
Wednesday, October 6, 2021
Infantile neuroaxonal dystrophy, Food, PLA2G6, Infant, Degenerative disease, Failure, FA, University of California, Patient, NDA, Lipid peroxidation, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Therapy, RT001, Hypotonia, Amyotrophic lateral sclerosis, FDA, Disorder, Death, Spasticity, AMD, PSP, Dihydroxy-E,Z,E-PUFA, INAD, University, Food and Drug Administration, LPO, Neurology, Comparative effectiveness research, LA, Disease, Autonomic nervous system, New Drug Application, Pneumonia, HIV disease progression rates, Mitochondrial membrane transport protein, Technology, DHA, ALS, Research, Oxidative stress, Tissue, Brain, Genetics, Radical (chemistry), LOS, Survival, SAP, Membrane, Neurodegeneration, Totality, Seizure, GLOBE, Metabolism, Pharmaceutical industry

LOS ALTOS, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases, today reported data from its Phase 2/3 clinical trial of RT001 in patients with infantile neuroaxonal dystrophy (INAD) and its concurrent natural history study of disease onset and progression in INAD patients. Results demonstrated statistically significant improvements in overall survival and progression free survival for patients treated with RT001 as compared to control. These survival endpoints included a combination of efficacy and safety measures. Additionally, clinical improvements were observed in patients receiving RT001 as measured by the Modified Ashworth Spasticity Scale, the study’s primary efficacy endpoint, and other measurements of efficacy as compared to patients in the natural history study. These single efficacy outcomes did not reach statistical significance likely due to the small study size.

Key Points: 
  • Results demonstrated statistically significant improvements in overall survival and progression free survival for patients treated with RT001 as compared to control.
  • The treatment study of RT001 included 19 INAD patients and the concurrent natural history study included 36 INAD patients as the control arm.
  • Patients in the treatment study received RT001 for a minimum period of one year with a 30-day treatment free follow up period.
  • Infantile Neuroaxonal Dystrophy is an ultra-rare, infantile genetic neurological disorder and part of a spectrum of diseases called PLA2G6-associated neurodegeneration.